Brazil’s health regulator authorizes new Pfizer vaccine production plant

The Pfizer/BioNTech consortium may now expand its production capacity thereby expediting the availability of batches for Brazil.

RIO DE JANEIRO, BRAZIL - The Brazilian health regulatory agency (ANVISA) has authorized the production of vaccines against Covid-19 in a Hospira company plant in the state of Kansas, USA. This step is required for the immunizer to be used in Brazil.

The plant may be used to manufacture vaccine doses developed by the Pfizer/BioNTech consortium, which has received authorization for use in Brazil and had a contract with the Ministry of Health for the purchase of 200 million doses this year.

The agency's authorization acknowledged the plant's "good manufacturing practices," one of the requirements for a . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?